Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Early diagnosis and treatment of PCOS are crucial to reduce health risks and costs.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Common skin conditions can greatly affect a person's mental health and social life.

The DNA convention was a valuable opportunity for learning and networking, especially after COVID-19.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.